Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dermalex Repair Scalp Psoriasis gel
130502000BBCEA0
|
Proprietary compound preparation BNF 1305020 | Other psoriasis preparations | Skin | No data available |
|
Dermidex Dermatological cream
130300000BPASA0
|
Proprietary compound preparation BNF 1303000 | Other topical anaesthetic and antipruritic preparations | Skin | No data available |
|
Desoximetasone 0.05% oily cream
1304000J0AAABAB
|
Desoximetasone | Desoximetasone | Skin | No data available |
|
Dettol antiseptic cream
1311050E0BBACAD
|
Dettol (Topical Cleanser) | Chloroxylenol | Skin | No data available |
|
Dettol antiseptic wash 0.198% spray
1311030D0BCAAAF
|
Dettol (Soap) | Benzalkonium chloride | Skin | No data available |
|
Deucravacitinib 6mg tablets
1305030L0AAAAAA
|
Deucravacitinib | Deucravacitinib | Skin | No data available |
|
Dianette tablets (Mylan)
1306020C0BBABAA
|
Dianette | Co-cyprindiol (Cyprote acetate/ethinylestradiol) | Skin | No data available |
|
Dimeticone 10% / Cetrimide 0.5% cream
1302020D0AAAHAH
|
Dimeticone (Barrier) | Dimeticone (Barrier) | Skin | No data available |
|
Dimeticone 10% cream
1302020D0AAAAAA
|
Dimeticone (Barrier) | Dimeticone (Barrier) | Skin | No data available |
|
Diphencyprone 0.001% in acetone liquid
130900000AABHBH
|
Generic compound preparation BNF 1309000 | Other shampoo and scalp preparations | Skin | No data available |
|
Diphencyprone 0.005% in acetone liquid
130900000AABIBI
|
Generic compound preparation BNF 1309000 | Other shampoo and scalp preparations | Skin | No data available |
|
Diphencyprone 0.01% in acetone liquid
130900000AABCBC
|
Generic compound preparation BNF 1309000 | Other shampoo and scalp preparations | Skin | No data available |
|
Diphencyprone 0.025% in acetone liquid
130900000AABDBD
|
Generic compound preparation BNF 1309000 | Other shampoo and scalp preparations | Skin | No data available |
|
Diphencyprone 0.05% in acetone liquid
130900000AABJBJ
|
Generic compound preparation BNF 1309000 | Other shampoo and scalp preparations | Skin | No data available |
|
Diphencyprone 0.075% in acetone liquid
130900000AABKBK
|
Generic compound preparation BNF 1309000 | Other shampoo and scalp preparations | Skin | No data available |
|
Diphencyprone 0.1% in acetone liquid
130900000AABLBL
|
Generic compound preparation BNF 1309000 | Other shampoo and scalp preparations | Skin | No data available |
|
Diphencyprone 0.125% in acetone liquid
130900000AABMBM
|
Generic compound preparation BNF 1309000 | Other shampoo and scalp preparations | Skin | No data available |
|
Diphencyprone 1% in acetone liquid
130900000AABNBN
|
Generic compound preparation BNF 1309000 | Other shampoo and scalp preparations | Skin | No data available |
|
Diphencyprone 2.5% in acetone liquid
130900000AABFBF
|
Generic compound preparation BNF 1309000 | Other shampoo and scalp preparations | Skin | No data available |
|
Diphencyprone 2% in acetone liquid
130900000AABEBE
|
Generic compound preparation BNF 1309000 | Other shampoo and scalp preparations | Skin | No data available |
|
Diphencyprone 3% in acetone liquid
130900000AABPBP
|
Generic compound preparation BNF 1309000 | Other shampoo and scalp preparations | Skin | No data available |
|
Diprobath bath emollient
1302011L0BDAAAC
|
Diprobath | Light liquid paraffin | Skin | No data available |
|
Dith 0.4%/Salic acid 2%/EW 25% in liq paraffin to 100% oint
1305020F0AAEZEZ
|
Dithranol (Topical) | Dithranol | Skin | No data available |
|
Dithranol 0.01% in Yellow soft paraffin
1305020F0AAEUEU
|
Dithranol (Topical) | Dithranol | Skin | No data available |
|
Dithranol 0.1% in Yellow soft paraffin
1305020F0AAEYEY
|
Dithranol (Topical) | Dithranol | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.